Health System

The FDA approves simulant prodrug for treatment of adult ADHD

Amitiza has gained a new indication-to treat irritable bowel syndrome with constipation in women.

Wyeth gets regulatory nod for constipation drug

A new nasal spray has been approved to help seasonal allergy sufferers.

The Centers for Medicare & Medicaid Services issues a final rule clarifying its position on the inclusion of insulin and exclusion of erectile dysfunction medications in the Medicare Part D program.

NCPA and the NACDS have amended their average manufacturer price lawsuit to include CMS' interim final rule on multiple-source drugs

UCB receives FDA approval for certolizumab pegol (Cimzia).

Aripiprazole receives new indication as adjunct to lithium or valproate

Two counties in Wisconsin are piloting a Get the Meds Out drug disposal program.

The feds have proposed more rules to tighten the marketing of Medicare Advantage and Part D plans.

The Centers for Medicare & Medicaid Services will require NPI numbers on claims submitted after May 23, 2008.

Aloxi has a new indication for the prevention of postoperative nausea and vomiting (PONV).

CVS Caremark announced a new cosmetics safety policy as part of its Corporate Social Responsibility report.

Medical devices featuring the Carmeda BioActive surface from Medtronic are being recalled because they are made with the contaminated heparin made in China.

A large group of physicians, pharmacists, and patients have pressed Congress to urge FDA to rescind its policy that bars the use of compounded estriol to treat menopause.

A Texas grocery chain is luring moms-to-be with a free prental vitamin offer.

A multidisplinary task force has produced a resource on emergency preparedness for health professionals.

NACDS releases a document stating its position on healthcare reform

Consumer Healthcare Products Association is expanding its Five Moms campaign to help prevent teen cough medicine abuse.

In testimony before a House subcommittee, a homecare organization labels the DMEPOS competitive bidding program as a train wreck.

A new pharmacy survey from Consumers Union found wide discrepancies in drug prices and a drop in patient consultations with pharmacists.

PharmaCentra is launching WellTouch First Fill to encourage patients to get their first prescription orders filled.

One lot of a mouthwash from Cardinal Health is being recalled due to bacterial contamination.

The National Community Pharmacists Association joins the United States Chamber of Commerce Global Intellectual Property Center to fight counterfeited and pirated prescription drugs.

Rite Aid is making technological changes to appeal to blind customers.

Wal-Mart has expanded its $4 generic offer to cover discounts for 90-day supplies and OTCs.

McKesson is settling allegations that it violated federal reporting provisions relating to its handling of controlled substances at six of its distribution centers.

Sickle cell disease (SCD) is life-defining. Those with this inherited blood disease never know when a crisis will disrupt their lives. They never know how long SCD is going to interfere with daily living. In many respects SCD determines an individual's quality of life, level of career success, personal finances, and perhaps even longevity-although over the past 30 years improved medical care has significantly improved the lifespan of individuals with SCD.

FDA alerts clinicians to serious infections associated with the use of Enbrel

The Centers for Medicare & Medicaid Services has issued an FAQ that explains about the use of a non-NPI for prescribers who are not covered entities.